Regeneration of the periodontium using enamel matrix derivative in combination with an injectable bone cement by Daniël A. W. Oortgiesen et al.
ORIGINAL ARTICLE
Regeneration of the periodontium using enamel matrix
derivative in combination with an injectable bone cement
Daniël A. W. Oortgiesen & Gert J. Meijer &
Antonius L. J. J. Bronckers & X. Frank Walboomers &
John A. Jansen
Received: 4 January 2012 /Accepted: 16 April 2012 /Published online: 3 May 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract
Objectives Enamel matrix derivative (EMD) has proven to
enhance periodontal regeneration; however, its effect is
mainly restricted to the soft periodontal tissues. Therefore,
to stimulate not only the soft tissues, but also the hard
tissues, in this study EMD is combined with an injectable
calcium phosphate cement (CaP; bone graft material). The
aim was to evaluate histologically the healing of a macro-
porous CaP in combination with EMD.
Materials and methods Intrabony, three-wall periodontal
defects (2×2×1.7 mm) were created mesial of the first
upper molar in 15 rats (30 defects). Defects were randomly
treated according to one of the three following strategies:
EMD, calcium phosphate cement and EMD, or left empty.
The animals were killed after 12 weeks, and retrieved sam-
ples were processed for histology and histomorphometry.
Results Empty defects showed a reparative type of healing
without periodontal ligament or bone regeneration. As mea-
sured with on a histological grading scale for periodontal
regeneration, the experimental groups (EMD and CaP/
EMD) scored equally, both threefold higher compared with
empty defects. However, most bone formation was mea-
sured in the CaP/EMD group; addition of CAP to EMD
significantly enhanced bone formation with 50 % compared
with EMD alone.
Conclusions Within the limits of this animal study, the
adjunctive use of EMD in combination with an injectable
cement, although it did not affect epithelial downgrowth,
appeared to be a promising treatment modality for regener-
ation of bone and ligament tissues in the periodontium.
Clinical relevance The adjunctive use of EMD in combina-
tion with an injectable cement appears to be a promising
treatment modality for regeneration of the bone and liga-
ment tissues in the periodontium.
Keywords Animals . Calcium phosphates . Periodontal
diseases . Guided tissue regeneration . Periodontal
Introduction
Periodontal disease leads to tissue destruction, such as epi-
thelial downgrowth and thereby loss of root cementum,
periodontal ligament (PDL), and alveolar bone. Currently,
the most predictable treatment is scaling and rootplaning of
the root surfaces, possibly in combination with surgery. As a
drawback, this treatment results only in arresting inflamma-
tion, thus preventing or slowing down further attachment
loss. As such, the outcome for this type of treatment is healing
with a long junctional epithelium [1]. Ideally, lost root cemen-
tum, PDL, and alveolar bone, should be regenerated.
Currently, such regeneration is sometimes partially
obtained with the use of enamel matrix derivative (EMD;
Emdogain®, Straumann, Basel, Switzerland) or guided tis-
sue regeneration (GTR) [2]. For example, a recent rat study
using an intrabony defect showed less gingival recession, a
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deeper sulcus, and shorter junctional epithelium upon EMD
treatment [3]. However, bone formation was minimal in
both EMD-treated group and untreated control group. Evi-
dently, regeneration of both hard (bone) as well as soft
periodontal tissue needs another approach. In view of this,
biodegradable calcium phosphate (CaP) cements have been
shown excellent candidates for bone regeneration. Such
cements largely consist of alpha tri-calcium phosphate to
enable adequate in vivo turn over, especially when the
cement is made porous by the incorporation of poly(DL-
lactic-co-glycolic acid) (PLGA) microspheres [4–8]. So
far, most tri-calcium phosphate materials used in clinical
periodontal regeneration therapy are applied in particulate
form and demonstrated to be encapsulated or to be resorbed
without evident periodontal regeneration. In contrast, inject-
able cement compositions have already been reported with
promising histological results for periodontal regeneration
[9, 10].
For the current investigation, it was hypothesized that
combining the positive properties of EMD and an inject-
able macroporous CaP will have a synergistic effect on
periodontal tissue healing. Thus, CaP together with EMD
might stimulate bone formation besides the regeneration
of the soft periodontal tissues. Therefore, the aim was to
evaluate histologically the healing of a macroporous CaP
in combination with EMD in a pre-validated defect mod-
el in rat [3].
Materials and methods
Enamel matrix derivative
EMD (30 mg/mL) was used according to the manufac-
turer’s recommendations in the designated experimental
groups. The exact composition of EMD is not disclosed
and the responsible reactive molecules are not yet iden-
tified, but EMD is thought to contain at least ameloge-
nins, which are dissolved in the carrier propylene glycol
alginate.
Calcium phosphate cement with PLGA microspheres
Preparation of the PLGA microparticles
PLGA with a 50:50 lactic to glycolic acid copolymer ratio
was used (molecular weight 17±1.6 kDa; Purasorb®,
Purac, Gorinchem, the Netherlands). PLGA microparticles
were prepared by an established double-emulsion-solvent
extraction technique ((water-in-oil)-in-water) as previously
described [7]. Microparticles were produced by injecting
500 μL demineralized water into a tube containing a solution
of 1,400 mg PLGA in 2 mL dichloromethane. This mixture
was emulsified (60 s) on a vortex (Genie 2, Scientific
Industries, Bohemia, New York, USA). Subsequently,
6.0-mL 0.3 % aqueous poly(vinyl alcohol) (PVA) solu-
tion was added and emulsified (60 s) on a vortexer to
produce the second emulsion. The mixture was then
added to 394 mL PVA solution and 400 mL of 2 %
aqueous isopropanol solution with rapid stirring (1 h).
Subsequently, the microparticles were allowed to settle
(15 min) and the solution was decanted. Then, the
microparticles were washed and collected through cen-
trifugation (1,500 rpm, 5 min), lyophilized, and stored
under argon at −20 °C until further use. The size
distribution of the PLGA microparticles (n0100) was
determined by image analysis (Leica Qwin®, Leica
Microsystems, Wetzlar, Germany). The morphology of the
PLGA microparticles was determined by observation with a
scanning electron microscope (JEOL 6400-LINK AN 10000
at 10 kV). The PLGA microspheres were 26±8 μm in diam-
eter and had a spherical and smooth appearance. The PLGA/
CaP cement showed signs of interconnecting pores. More
specific details have been previously reported [7].
Preparation of PLGA/CaP cement composite
CaP consisted of 85 % alpha tri-calcium phosphate, 10 %
dicalcium phosphate anhydrous, and 5 % precipitated
hydroxyapatite.
PLGA microparticles were added to the CaP powder
in a PLGA/CaP weight ratio of 20/80. For delivery into
the defect, a 2-mL syringe (Sherwood Medical, Den
Bosch, the Netherlands) was closed at the tip with a
stopper and filled with 500 mg of the PLGA/CaP mix-
ture. Preoperatively, syringes filled with PLGA/CaP
powder were sterilized by gamma radiation (25 kGy,
Isotron B.V., Ede, the Netherlands). Before surgery,
sterile cement liquid (1 % Na2HPO4; 200 μL) was
added to provide injectability. Then, the syringe was
placed in a mixing apparatus (Silamat®, Vivadent,
Schaan, Lichtenstein) and mixed (15 s). The stopper
was removed, and the cement was injected into the
defect.
Animals
Fifteen healthy adult Wistar rats, weighing approximately
350–400 g were used. The Animal Ethical Committee of
Radboud University Nijmegen (RU-DEC 2008-091) ap-
proved the study protocol. All procedures were in accor-
dance with the national guidelines for the care and use of
laboratory animals. The animals were screened for good
physical condition and were specific-pathogen free. Food
pellets and water were provided ad libitum but were with-
held overnight pre-operatively.
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Surgical procedures
Surgery was performed using general inhalation anaesthesia
by means of intubation. To minimize peri- and postoperative
pain, carprofen (Rimadyl® Pfizer, Capelle aan de IJssel, the
Netherlands; 50 mg/mL s.c., 0.01 mL/kg bodyweight) was
given pre-operatively, and continued the first 2 days post-
operatively. Anaesthesia was maintained by a mixture of
nitrous oxide, isoflurane 2–3 %, and oxygen through a
constant volume ventilator and monitored, using a pulsoxy-
meter, to ensure that an appropriate level of anaesthesia was
achieved and maintained. During operation, animals were
positioned in a head-restraining device to allow proper
access to the maxillary molar area. Surgery was performed
with the aid of magnifying loupes (×2.5) and strong light by
one surgeon (DO). Bilateral intrabony three-wall defects
were created mesial of both maxillary first molars. A local,
adrenaline containing, dental anaesthetic (Ultracain D-S®,
Aventis Pharma BV, Gouda, the Netherlands) was used to
reduce the bleeding tendency and for pain management. A
3-mm-long incision was made on the alveolar ridge
(Fig. 1a). Flaps were raised in order to expose the tooth
and alveolar bone (Fig. 1b). Using a piezoelectric device
(OT5 B-tip; 1.7 mm in diameter; Piezosurgery®, Mectron,
Carasco, Italy) a three-wall intrabony defect was made along
the root surface. Thereafter the residual bone, PDL, and root
cementum were carefully removed from the root surface,
using a less abrasive tip (OP5-tip) (Fig. 1c). This tip was
also used to finalize the size of the defect (width × length ×
depth; 2×2×1.7 mm) (Fig. 2c) while constantly carefully
monitoring the dimensions using a periodontal probe. Pilot
experiments on preparing the defects showed that this meth-
od led to very consistent defect sizes as assessed in post-
mortem measurements (data not shown). Prior to the desig-
nated treatment all root surfaces were treated with 24 %
ethylenediaminetetraacetic acid (EDTA; PrefGel™, Strau-
mann®, Basel, Switzerland) during 2 min according manu-
facturer’s recommendation. Subsequently, the defects were
rinsed with sterile saline, dried with a sterile gauze and, if
indicated, filled immediately thereafter (Fig. 1d).
Groups were randomly divided over all animals. The first
group was left empty for spontaneous healing (controls, n0
10). The second group received only EMD (n010). In the
third (CaP/EMD) group first EMD was applied. Subse-
quently, CaP was injected into the defect (n010) (Fig. 1e).
EMD was used as indicated by the manufacturer. Briefly,
after EDTA application the defects were thoroughly rinsed
with sterile saline, dried with sterile gauzes and, by pipet-
ting, 15 μL of EMD was applied strictly onto the root
surface. After EMD application, a 2-min waiting time for
protein adsorption was kept. Subsequently, CaP was used to
completely fill the defect to the original contour of the bone,
i.e., ~6.8 mm3 (2×2×1.706.8 mm3).
Finally, the flaps were repositioned, using resorbable
sutures (Vicryl® 4-0, Ethicon Products, Amersfoort, the
Netherlands) (Fig. 1f). During the first ten postoperative
days, the animals were fed with powdered food for minimal
wound disturbance. After 12 weeks, the animals were
euthanized by CO2 inhalation, samples were harvested,
and processed for histological analysis [3].
Fig. 1 Overview of surgical procedure: a a 3-mm incision was made
mesial of the maxillary molar; b muco-periosteal flaps were raised on
the buccal and palatal aspect; c the OT5 B tip is displayed next to a
standard 10-mm periodontal probe on the left, on the right observe the
OP5-tip; d the created defect, prior to the final corrections standardiz-
ing the defect; e an example of a defect treated with the CaP cement
after the application of EMD; f the flaps sutured with 4–0 resorbable
sutures
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Fig. 2 a Bone height was
measured mesial of the
maxillary molar (Masson
staining; original
magnification, ×2.5). A line
connecting the furcations of the
neighboring molars was drawn.
This black line indicates the
connected furcations and was
then compared with the bone
height mesial of the first molar;
shown is a non-operated sample
indicating that this drawn line
indicates the original bone
height mesial; b the black line
with asterisk indicates the dif-
ference between the original
bone height and the reduced
bone height after surgery;
shown a sample from the EMD-
treated group (Masson staining;
original magnification, ×2.5); c
diagram to show the dimen-
sions of the three-wall defect
and the measurements taken for
the histomorphometrical
analysis
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Histological preparation
First, the complete maxilla was dissected and excess tissue
removed. After fixation in buffered formaldehyde (pH 7.4)
10 % for 24 h, the specimens were decalcified for 6 h under
a low voltage current in a decalcifying bath (TDE™ 30 bath,
Sakura Finetek Europa B.V., Zoeterwoude, The Nether-
lands) and subsequently dehydrated in a graded series of
ethanol (70–100 %). Before embedding, the molars were
stained with black ink to ensure that sections were made in
the area of interest. Maxillas were split in the middle, and
the hemi maxillas were embedded in Paraplast paraffin
(Klinipath B.V., Duiven, the Netherlands). Sections of
6 μm were cut in mesio-distal direction, stained with hema-
toxylin–eosin and trichrome (Masson modification Gold-
ner). Light microscopical evaluation of all sections was
done using an optical microscope (Leica MZ12, Leica BV,
Rijswijk, the Netherlands) and consisted of a complete
morphological qualitative description and quantitative anal-
ysis of the tissue response. For the quantitative analysis, a
histological scoring system was developed and a compre-
hensive assessment was performed on three sections per
specimen for each of both staining in the center of the
original defect site [11, 12]. Each section was assigned a
score and from the scores of all sections in one group the
average score of the groups was calculated. These assess-
ments were separately performed by two examiners blinded
to treatment group.
Histomorphometry and statistical analysis
Following histomorphometrical parameters were assessed:
1. Root damage and root resorption were scored on a 2-
point grading scale (yes/no) based upon the histological
images. Root damage was recorded when sharp, straight
substance removal could be observed, i.e., caused by
instrumentation. Root resorption was documented when
irregular substance removal could be observed. A con-
tingency table was made and data were compared using
a Chi-square test, in a statistical program (Instat version
3.05, GraphPad Software, San Diego, CA, USA).
2. Inflammation was scored on a 4-point scale (Table 1).
Subsequently, groups were compared with a two-way
analysis of variance (ANOVA) with post-hoc Tukey
testing. A higher score represents less inflammation.
3. Epithelial downgrowth was measured from the gingival
margin to the most apical extent of the junctional epi-
thelium (Fig. 2b). The total tooth length was measured
from the apex to the mesial cusp of the molar. To
compensate for deviations in alignment of the histolog-
ical slides, relative values were used by dividing the
length for epithelial downgrowth by the total tooth
length. Before analysis, these values were inverted,
i.e., a higher score represents a more beneficial tissue
response (less epithelial downgrowth). Hereafter, each
score received a rank number and comparisons between
groups were made using ANOVA and post-hoc Tukey
testing.
4. PDL formation and connective tissue attachment (CT)
were scored on a 4-point grading scale (Table 1). PDL
formation included new (a) cellular cementum forma-
tion in combination of perpendicularly oriented fibers
inserted into the cement and bone. CT attachment was
regarded as the supracrestal connective tissue adhesion
to the root surface without new cementum formation but
in presence of perpendicularly orientated of fibers [13,
14]. Subsequently, groups were compared with ANOVA
and post-hoc Tukey testing. A higher score represents
better periodontal healing.
5. The bone height of the defect located mesially of the
maxillary molar was measured as follows. First a refer-
ence line was drawn interconnecting the furcation
heights of the neighboring molars (Fig. 2a; a non-
operated sample). Subsequently, from this reference line
to the bottom of the created defect, a second line (with
asterisk) was drawn parallel to the mesial root of the
first molar (Fig. 2b; a sample from the EMD group).
Alike epithelial downgrowth, this difference was mea-
sured as a relative value to the total tooth length. All
scores in each group were sorted low to high, i.e., a
higher score indicated more bone height. Finally, each
score received a rank number and a comparison between




All surgical and recovery procedures were uneventful ex-
cept for the rats treated with the CaP; during the first
postoperative 2–3 days considerable extra-oral swelling
was observed. Still, all animals gained weight in a compa-
rable manner. No other macroscopic signs of inflammation
were observed during the entire healing period.
Descriptive histology
The periodontal defects could still be detected in all samples. In
some samples (10 out of 30) the tiny bone wall to the sinus
cavity was penetrated. The acellular cementum was always
completely removed from the root surface together with the
supporting alveolar bone, which only occasionally resulted in a
slightly damaged root. In some samples, of different treatment
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groups, root resorption could be observed except, for the
EMD-treated groups.
A common finding in the empty group was epithelial
downgrowth to the level to which the cementumwas removed
(Fig. 3a, b). In addition, empty defects showed very limited
signs of new cementum, new bone or PDL regeneration. A
collapse of the soft tissues could be observed as a consequence
of the bony defect. A detailed image of the supra-crestal tissue
is presented in Fig. 4a, b. Consistently, in all sections a random
orientation of the supra-crestal fibers instead of the normal
structured perpendicular orientation was observed.
Within the EMD-treated group limited evidence of bone
formation was seen (Fig. 3c, d). Some samples (3 out of 10)
showed evidence of cementum formation with PDL fibers
embedded into the pre-existing bone, which was limited to
the apical part of the defect and always in proximity of pre-
existing cementum (Fig. 4c, d). Overall, a very limited inflam-
matory response was observed in all EMD specimens. The
supra-crestal connective tissues showed functional orientation
of the fibers (Fig. 4c, d). In the specimens that had not formed
new cementum, always a CT adhesion was present.
The CaP/EMD group (Fig. 3e, f) showed for PDL and CT
comparable histological results with the EMDgroup; i.e. supra-
crestal, functionally orientated fibers (Fig. 4e, f). In the CaP/
EMD group consistently more bone formation was observed in
the apical part of the defect compared with the empty and EMD
groups. A few samples (two out of ten) showed remnants of the
CaP, however, never in contact with the root surface.
Histomorphometry and statistical analysis
In all groups damage and resorption of the roots, inflammatory
response, epithelial downgrowth, healing of periodontal fibrous
tissue and bone healing were measured. In each assessment, a
higher score was indicative for a more favorable tissue re-
sponse. As previously mentioned, all data were collected by
two examiners that were blinded to the treatment performed.
The inter-examiner agreement was already initially very high.
However in case of discrepancy in score between the two
examiners, this was dissolved by a combined viewing of the
specific specimen and subsequent discussion always led to an
agreement on the score to be used for the specimen.
In all groups some root damage was observed; three sam-
ples out of the empty group (n010), five samples out of the
EMD group (n010), and six out of the CaP/EMD group (n0
10). This was also the case for root resorption, four samples
out of the empty group (n010), two samples out of the CaP/
EMD group (n010), however the EMD group did not exhibit
root resorption. There were no statistically significant differ-
ences in the amount of root damage and resorption between all
groups (p00.89 and 0.89 respectively), indicating that root
damage or resorption were no confounding parameters of
influence in the analysis of any group.
Least inflammation was noted in the EMD group and
most in the empty group (Fig. 5a) (p<0.05). The group
treated with EMD and CaP, showed an average degree of
inflammation, in between that of both other groups.
The least epithelial downgrowth was measured in the
EMD-treated group. The results for the other groups were
quite similar, and not significantly different from the EMD
group (Fig. 5b).
For PDL and CT healing, the empty group showed the
worst score whereas both experimental groups (EMD or CaP/
EMD) performed significantly better, increasing threefold
from 0.5 (empty) to 1.4–1.5 (EMD or CaP/EMD) (Fig. 5c).
Bone was least formed in the empty group, while most
bone was formed in the CaP/EMD group. (Fig. 5d). Inclu-
sion of CAP to EMD significantly enhanced bone formation
in the EMD group, from score 1.9 to 2.9; an increase of
approximately 50 %.
Discussion
The best treatment of periodontal defects, today, is only to






Inflammation 1 Masses of inflammatory cells
2 Many inflammatory cells, showing some fibroblasts
3 Immature connective tissue, showing fibroblasts with few inflammatory cells
4 Normal appearance of connective tissue with few inflammatory cells
Periodontal
healing
0 No PDL regeneration, no connective tissue adhesion, random supracrestal fiber orientation
and, epithelial downgrowth
1 No PDL regeneration but CT adhesion with perpendicular fiber orientation supracrestally
2 Evidence of PDL regeneration limited to the apical part of the defect and, CT adhesion
with perpendicular fiber orientation supracrestally
3 Complete PDL regeneration
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all possible, the periodontal condition should be brought
back into its original condition. For this purpose, regenera-
tive techniques come into view. As in periodontal defects
both soft tissues (PDL and CT) as also hard tissues (cement
and alveolar bone) need to be reconstructed, we hypothe-
sized that the combination of EMD with a calcium phos-
phate cement (CaP) could accomplish such periodontal
healing. To date, defects left empty, showed merely repair.
EMD application, indeed showed periodontal soft tissue
(PDL and CT) healing, however, limited bone regeneration
was observed. The combination of EMD and CaP appeared
to have a synergistic effect, stimulating both soft periodontal
tissue healing and bone regeneration.
Regarding our animal model, it is obvious that the herein
used model has certain limitations. Canine models, as regu-
larly used in periodontal regenerative studies, allow for exam-
ple preparation of larger defects. Also a notch in the root, that
can serve as a reference point for future histological evalua-
tion, can be prepared. Obviously, the model used for this study
is too small for such a notch, however in the near future
perhaps in vivo (micro-)CT might be feasible to allow for
more accurate, even three-dimensional, measurements.
In the present study small three-wall defects were created
artificially in rats. It might be assumed that this size of
defect will heal spontaneously and does not require the use
of biomaterials. However, as can be observed in our results,
Fig. 3 Histological overview
of the different treatment
groups. a Empty defect (HE
staining; original
magnification, ×2.5); b empty
defect (Masson staining;
original magnification, ×2.5); c
EMD (HE; original
magnification, ×2.5); d EMD
(Masson; original
magnification, ×2.5); e CaP/
EMD (HE; original
magnification, ×2.5); f CaP/
EMD (Masson; original
magnification, ×2.5). ABC
alveolar bone crest, C
cementum, D dentin of the root,
M indicating the first molar of
the maxilla, projected all in the
same fashion (apex down).
Asterisk, apical extent of the
junctional epithelium. Double
asterisk, supra-alveolar tissues
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the empty three-wall defects in fact showed limited sponta-
neous healing. We feel that in spite of the overall dimen-
sions, the defect size is still relatively large defect to this
small animal model.
Another point of debate in the field of preclinical peri-
odontal research is whether defects should be created surgi-
cally, like in this study, or induced chronically (i.e., plaque
infection), or even the combination of both. Positive aspects
of plaque-induced periodontal breakdown are that a dis-
eased root surface is created. However, also this situation
is still not completely similar to natural occurring periodon-
titis. An even more important point is that defects may vary
between animals, making subsequent treatment and analysis
challenging or even impossible. Additional disadvantages
Fig. 4 Details of different
treatment groups. a Supra-
crestal tissues (asterisk); show-
ing random orientation of the
fibers in the empty group (HE;
original magnification, ×2.5),
please observe the supra-crestal
tissues are detached from the
rootsurface, indicating a weak
bond between the two tissues; b
another example of an empty
group sample (Masson; original
magnification, ×2.5); c detail of
a functionally orientated supra-
crestal connective tissue attach-
ment (asterisk), showing new
cementum formation (c) in a
EMD sample (HE; original
magnification, ×20); d detail of
a functionally orientated supra-
crestal connective tissue attach-
ment (asterisk), showing new
cementum formation (c) in an-
other EMD sample (HE; origi-
nal magnification, ×10); e detail
of a functionally orientated
supra-crestal connective tissue
attachment, showing new ce-
mentum formation in a sample
treated with CaP/EMD
(Masson; original magnifica-
tion, ×10); f supra-crestal con-
nective tissue attachment in
CaP/EMD group (HE; original
magnification, ×10); g higher
magnification of (d) showing
new cementum (c) (HE; origi-
nal magnification, ×20);
h higher magnification of (e)
showing new cementum (c)
(Masson; original magnifica-
tion, ×20). C cementum, D
dentin of the root. Asterisk,
supra-alveolar tissues
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are prolonged experimental time due to additional handling
of the animals. Surgical creation of defects on the other hand
has certain positive aspects, such as that defect sites can be
standardized and creation is much faster. The animal model
used in this study does not fully represent a periodontal
disease state and likewise has several limitations as a model
for periodontal regeneration (e.g., differences in periodontal
tissues and histopathological features). Nevertheless, the
currently used model is cost-effective and especially suit-
able for initial studies.
Regarding our study setup, the handling of the cement
needs further attention. Although it appeared possible to
create defects of the same size, the bone architecture in the
defect region varied from one rat to another. Due to this
variation, occasionally, the bone separating the sinus muco-
sa from the periodontal defect was damaged, which resulted
in bleeding, thereby frustrating to get the defect dry prior to
applying EMD and/or CaP. Moisture compromises the set-
ting of the CaP, and as a consequence, might have reduced
the mechanical strength of the CaP as also was reported for a
rat cranial defect [15]. Another aspect is that sometimes
residue of CaP material could be observed. In order to
obtain fast resorption of the grafts, a low molecular PLGA
was included in the CaP cement. However, after 12 weeks of
healing still some grafted CaP was seen, which corroborates
with other studies in which CaP was injected in periodontal
[16] or other bone defects [6].
In the CaP-treated group, all rats showed initial swelling,
which has not been reported before [6, 16, 18]. It is has been
described that graft particles, in the region of interaction
between the graft and host bone, can cause an inflammatory
response [19]. In our study, due to possible initial instability
of the CaP, such fragments might have caused this transient
inflammatory response and associated swelling.
Another pit fall is primary loss of CaP after its application.
To date, in a human study, the authors mentioned that in 6 out
of the 15 patients treated with CaP, such an exfoliation did
occur [9]. Although in the present study flaps could always be
closed without compromise, as also the animals were moni-
tored for graft exfoliation during the first postoperative days
and in addition powdered food was offered, exfoliation can
never be excluded totally [10, 17]. In a recent human study
using a particulated biphasic calcium phosphate (BCP) either
or not with EMD, graft exfoliation was not described; this
might be due to differences in the used grafting materials;
particulated versus injectable that needs to set in situ. How-
ever, clinically, no advantages were reported when BCP was
used in combination with EMD [20].
No differences in epithelial down growth could be ob-
served for the combined therapy with CaP and EMD or
Fig. 5 Histomorphometrical data. a Inflammatory response, b epithelial downgrowth, c periodontal regeneration, and d bone regeneration. *P<
0.05; **P<0.01; ***P<0.001
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EMD alone in our study. This is exactly in line with what
others found in clinical research. For example, a recent
meta-analysis also showed no benefits for combination
therapies with EMD [21]. In this meta-analysis, numer-
ous different materials and EMD have been compared.
In this meta-analysis, clinical data have been compared
but no histological data have been reported. Even though in
the clinic the difference in clinical parameters might not
justify combined use, this might be different on a histological
level. Therefore, we feel that combination therapy is worth
further histological evaluation for potential benefits for
clinical treatment.
Most periodontal regeneration studies are conducted in
dogs, which allows careful plaque control, the application of
local antiseptics and even brushing. This is impossible in
rats, which might have affected the results negatively. From
human GTR studies, it is well known that plaque control is
of upmost importance [22].
As bone remodeling is different between humans, rats,
and canines, graft-material-associated changes may not be
as apparent in the human situation where there is a lower
rate of remodeling [23].
The histological and histomorphometrical findings indi-
cate that the reparative type of healing, as observed in the
empty group in our experiment, is consistent with numerous
published reports [1, 3, 13, 24]. Our experiment showed that
even three-wall periodontal defects did not regenerate spon-
taneously. Although these empty defects were also treated
with EDTA, like both experimental groups, it is well know
from literature that EDTA treatment does not have any
benefits as mono-therapy [25, 26]. Consistent with litera-
ture, ankylosis near the CaP cement was never observed [16,
27]. One study reports formation of cementum and PDL
between the root and CaP [16]. The authors postulated that
CaP acts much like a “membrane” in providing space main-
tenance and wound stabilization. Possibly, in our study the
CaP cement was initially not stable enough to elucidate
similar effects.
Using the same rat model, comparable results were
found for empty defects (no regeneration), or when
EMD was used (regeneration of the PDL but no bone
formation) [3]. Also in a dog study, empty defects
showed only a reparative type of healing while EMD-
treated defects demonstrated varying amounts of new
cementum but hardly any regenerated bone volume
[13]. Adding CaP, however, with or without EMD
showed significant more cementum and bone regenera-
tion. In this study, the importance of soft tissue support
was emphasized while avoiding immediate contact be-
tween the biomaterial and the root [13]. Follow-up
investigations have to be confirmed whether CaP ce-
ment only serves as wound stabilizer or if its osteocon-
ductive properties are the determining factor.
Conclusions
Within the limits of this rat study, the application of
EMD, either or not, in combination with calcium phos-
phate cement enhanced PDL formation. The additional
use of an injectable calcium phosphate cement resulted
in more bone formation compared with an empty defect
or a defect treated with EMD only. The combination of
EMD and calcium phosphate cement resulted in the
most favorable effects for respectively PDL formation
and bone regeneration. Although no effect on epithelial
down growth could be assessed, the adjunctive use of
calcium phosphate in combination with EMD is a prom-
ising treatment modality for regeneration of bone and
ligament tissues in the periodontium.
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